In our study to discover antitumor antibiotics from microorganisms, ansamycin antibiotics, trienomycins A (1), B (2), and C (3) have been found in the culture broth of Streptomyces sp. No. 83-16 as strong cytotoxic compound against HeLa S3 cells.D This study was undertaken to isolate further minor components from the broth. Trienomycins D (4) and E (5) were consequently isolated.
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Fermentati on
The inoculum for antibiotic production was prepared in a medium containing glucose 2%, peptone 0.5%, meat extract 0.5%, dry yeast 0.3%, NaCl 0.5%, CaCO3 0.3% (ajusted to pH 7.0 before sterilization).
A 250-ml Erlenmeyer flask containing 30ml of this medium was inoculated from a slant of Streptomyces sp. No. 83-16. The flask was incubated at 28°C on a rotary shaker at 220rpm for 72 hours. Six ml of this seed culture was transferred to 300 ml of the same medium in 2-liter flasks and incubated as above for 48 hours. 1.5-liter of the second seed was used to inoculate a 30-liter jar fermentor containing 18 liters of the following medium: Glucose 4%, yeast extract 1.5%, soy bean meal 0.1%, NaCl 0.5%, CaCO3 0.3% in tap water (ajusted to pH 7.0 before sterilization). The fermentation was carried out for 72 hours at 28°C with an air flow of 15 liters per minute and an agitation rate of 250rpm. Antibiotic production was monitored by HPLC. Isolation To the whole broth was added 8 liters ofPrOH, 479 and ajusted to pH 4.9 with cone HCL The above mixture was filtered with an aid of Celite.
The filtrate (23 liters) was passed on Diaion HP-20 (2 liters) and the column was washed with 40% aq acetone and eluted with 65% aq acetone. After evaporation of solvent, the residue was extracted with EtOAc. The extract was concentrated to a small volume, and addition of «-hexane afforded crude trienomycin complexes. The crude complex was dissolved in acetone, applied to a column of Diaion HP-20SS (2 liters) and eluted with 50% aq acetone.
The fractions of trienomycin A containing trienomycins D and E were concentrated, and extracted with EtOAc. The extract was concentrated to a small volume, and addition of w-hexane afforded trienomycin complexes as colorless powder. Further purification of trienomycins D (4) and E (5) was accomplished by preparative HPLC (YMC pack D-ODS-10 (20x250mm)).
The column was eluted with 65% aq MeOHas a mobile phase. The resulting fractions were monitored by HPLC (YMC pack A-312 ODS (6 x 150mm)) using 65% aq MeOHas a mobile phase. The fractions containing pure trienomycin D (4) were combined, concentrated, and extracted with EtOAc.
The extracts were concentrated to a small volume, to which w-hexane was added to give 5mg of pure trienomycin D (4) moiety is attached to the alanyl moiety of trienomycin E (5). From all of accumulated data described above, structure of trienomycins D (4) and E (5) were concluded to be 4 and 5 (Fig. 1), respectively.
Biological Properties of Trienomycins D and E
Trienomycins D (4) and E (5) were shown to exhibit cytotoxic activity against HeLa S3 cells. Whenthe cells were exposed to the antibiotics for 3 days, the growth of HeLa S3 cells were inhibited at concentration of 0.022^g/ml of trienomycin D (4) and 0.104 //g/ml of trienomycin E (5). Trienomycins D (4) and E (5) exhibited 2~5-fold weaker activity than trienomycin A (1).
